Starting Wednesday, millions of Medicare-qualifying adults will have access to popular medications for weight loss at deep discounts through a temporary federal program called the Medicare GLP-1 Bridge.

Many seniors may be unaware of the landmark coverage shift starting on July 1, with limited advertising seen from the government or Eli Lilly and Novo.

Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program that launches July 1.

Popular Novo Nordisk and Eli Lilly drugs are included

Medicare enrollees as of July 1 can get GLP-1s covered by Part D prescription insurance as part of a trial program until the end of 2027.